Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results
May 1 20:14
Pfizer | 8-K: Poll Results of Pfizer Meeting
Apr 29 22:22
Pfizer | DEFA14A: Others
Apr 11 23:04
Pfizer | DEFA14A: Others
Apr 11 23:00
Pfizer | DEFA14A: Others
Apr 11 23:00
Pfizer | DEFA14A: Others
Apr 9 22:34
Pfizer | DEFA14A: Others
Mar 29 04:26
Pfizer | DEFA14A: Others
Mar 29 04:17
Pfizer | DEFA14A: Others
Mar 14 21:09
Pfizer | DEF 14A: Definitive information statements
Mar 14 21:09
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 24 05:42
Pfizer | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 24 05:41
Pfizer | 8-K: Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Jan 30 21:07
Pfizer | 8-K: Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Jan 10 13:00
Pfizer | 8-K/A: Pfizer Completes Acquisition of Seagen
Dec 15, 2023 06:04
Pfizer | 8-K: Pfizer Completes Acquisition of Seagen
Dec 14, 2023 20:51
Pfizer | 8-K: Pfizer Provides Full-Year 2024 Guidance
Dec 13, 2023 20:44
Pfizer | 8-K: Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
Dec 13, 2023 05:35
Pfizer | 8-K: Pfizer Reports Third-Quarter 2023 Results
Oct 31, 2023 20:04
Pfizer | 8-K: Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
Oct 14, 2023 05:30
No Data
No Data